Colorectal cancer Trials in Bournemouth, United Kingdom
Conditions / Colorectal cancer / Bournemouth, United Kingdom
Clinical trials for Colorectal cancer investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04050345 | Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer | RECRUITING | — |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer | COMPLETED | PHASE3 |
| NCT00182715 | Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | UNKNOWN | PHASE3 |
| NCT00482222 | Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | UNKNOWN | PHASE3 |
| NCT00389870 | Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil | COMPLETED | PHASE3 |
| NCT01326000 | A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE2 |
| NCT02056691 | EDICT - Exercise inDuced Changes In Colorectal Cancer Tissues | COMPLETED | NA |
| NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | COMPLETED | PHASE2/PHASE3 |
| NCT00383695 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer | UNKNOWN | PHASE2 |
| NCT00640081 | Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | COMPLETED | PHASE2 |